U.S. Markets closed

Quest Diagnostics Incorporated (DGX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
102.11+0.56 (+0.55%)
At close: 4:02PM EDT
People also watch

Quest Diagnostics Incorporated

3 Giralda Farms
Madison, NJ 07940
United States

IndustryMedical Laboratories & Research
Full Time Employees43,000

Key Executives

Mr. Stephen H. RusckowskiChairman, Chief Exec. Officer and Pres2.75MN/A60
Mr. Mark J. GuinanChief Financial Officer and Exec. VP1.13MN/A55
Ms. Catherine T. DohertySr. VP and Group Exec. of Clinical Franchise Solutions & Marketing1.01M1.55M54
Dr. Jon R. Cohen M.D.Sr. VP and Group Exec. of Diagnostic Solutions991.98kN/A62
Mr. James E. DavisExec. VP of Gen. Diagnostics1.05MN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company’s Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene-based and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, and phlebotomists in physician offices. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Madison, New Jersey.

Corporate Governance

Quest Diagnostics Incorporated’s ISS Governance QualityScore as of September 1, 2017 is 4. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.